Document is current
Any future updates will be listed below
-
Authors
Maheswaran, Shivahamy
Medford, Arielle J.
Stryjewski, Tomasz P.
Thai, Janice N.
Wander, Seth A.
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 21 June 2025
First Online: 7 July 2025
Declarations
:
: AJM: AJM has served as an advisor/consultant for AstraZeneca, Guardant Health, Illumina, Myriad Genetics, Natera, SAGA Diagnostics, Novartis, Edgewood Oncology, and Science for America, outside the submitted work. TPS: TPS reports no conflict of interest with the content of the herein manuscript. Other professional relationships include: Alcon (Consultant), Aldeyra Therapeutics (Consultant, Equity, Patents), Alimera Science (Advisory Board), EyeCool Therapeutics (Consultant, Equity, Patents), Gyroscope Therapeutics (Research Support), Hubble Therapeutics (Consultant, Equity), Mass General Brigham (Patents, Royalties), Roche (Research Support), Orchard Surgical Center (Equity), Pykus Therapeutics (Consultant, Equity, Patents), Samsara Vision (Research Support), Tallman Eye Associates (Employee) SAW: Consulting/Advisory Board: Foundation Medicine, Veracyte, Hologic, Eli Lilly, Biovica, Pfizer/Arvinas, Puma Biotechnology, Novartis, AstraZeneca, Genentech, Regor Therapeutics, Menarini. Education/Speaking: Eli Lilly, Guardant Health, 2ndMD. Institutional Research Support: Genentech, Eli Lilly, Pfizer/Arvinas, Nuvation Bio, Regor Therapeutics, Sermonix.
